Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Drappatz

Showing results (11-20 of 130) with videos related to

Pageof 13
Sort By:
Expert Review of Neurotherapeutics|November 3, 2006
Novel therapies for meningiomasPatrick Y Wen, Jan Drappatz
Expert Review of Neurotherapeutics|November 3, 2006
Chemotherapy and targeted molecular therapies for brain metastasesJan Drappatz, Patrick Y Wen
The Oncologist|February 1, 2021
Safety of Direct Oral Anticoagulants in Central Nervous System MalignanciesAndrew W Swartz, Jan Drappatz
Expert Review of Anticancer Therapy|June 9, 2006
Malignant gliomas: strategies to increase the effectiveness of targeted molecular treatmentPatrick Y Wen, Santosh Kesari, Jan Drappatz
Current Opinion in Oncology|October 9, 2008
Antiangiogenic therapy in malignant gliomasAndrew D Norden, Jan Drappatz, Patrick Y Wen
Expert Review of Neurotherapeutics|April 7, 2009
Therapeutic strategies for inhibiting invasion in glioblastomaJan Drappatz, Andrew D Norden, Patrick Y Wen
Current Neurology and Neuroscience Reports|April 8, 2009
Advances in meningioma therapyAndrew D Norden, Jan Drappatz, Patrick Y Wen
The Lancet. Neurology|November 15, 2008
Novel anti-angiogenic therapies for malignant gliomasAndrew D Norden, Jan Drappatz, Patrick Y Wen
Nature Reviews. Neurology|October 15, 2009
Antiangiogenic therapies for high-grade gliomaAndrew D Norden, Jan Drappatz, Patrick Y Wen
Journal of Neuro-Oncology|May 21, 2018
Retrospective study of nivolumab for patients with recurrent high grade gliomasMegan Mantica, Ashley Pritchard, Frank Lieberman, et al.
Pageof 13

Showing results (11-20 of 130) with videos related to

Sort By:
Pageof 13
Expert Review of Neurotherapeutics|November 3, 2006
Novel therapies for meningiomasPatrick Y Wen, Jan Drappatz
Expert Review of Neurotherapeutics|November 3, 2006
Chemotherapy and targeted molecular therapies for brain metastasesJan Drappatz, Patrick Y Wen
The Oncologist|February 1, 2021
Safety of Direct Oral Anticoagulants in Central Nervous System MalignanciesAndrew W Swartz, Jan Drappatz
Expert Review of Anticancer Therapy|June 9, 2006
Malignant gliomas: strategies to increase the effectiveness of targeted molecular treatmentPatrick Y Wen, Santosh Kesari, Jan Drappatz
Current Opinion in Oncology|October 9, 2008
Antiangiogenic therapy in malignant gliomasAndrew D Norden, Jan Drappatz, Patrick Y Wen
Expert Review of Neurotherapeutics|April 7, 2009
Therapeutic strategies for inhibiting invasion in glioblastomaJan Drappatz, Andrew D Norden, Patrick Y Wen
Current Neurology and Neuroscience Reports|April 8, 2009
Advances in meningioma therapyAndrew D Norden, Jan Drappatz, Patrick Y Wen
The Lancet. Neurology|November 15, 2008
Novel anti-angiogenic therapies for malignant gliomasAndrew D Norden, Jan Drappatz, Patrick Y Wen
Nature Reviews. Neurology|October 15, 2009
Antiangiogenic therapies for high-grade gliomaAndrew D Norden, Jan Drappatz, Patrick Y Wen
Journal of Neuro-Oncology|May 21, 2018
Retrospective study of nivolumab for patients with recurrent high grade gliomasMegan Mantica, Ashley Pritchard, Frank Lieberman, et al.
Pageof 13